1. Market Research
  2. > Pharmaceutical

The business of medicines: must-read market reports and statistics

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
50 votes

Global Pharmaceutical Industry Overview

The pharmaceutical industry consists of companies involved in the research, development and marketing of drugs and biologics.

The pharmaceutical market was valued at $1 trillion in 2013, according to IMS. The market grew at a 4% compound annual growth rate (CAGR) from 2009 to 2013. It grew well in 2010 and 2011 before a decline in growth in 2012 and 2013.

Pharmaceutical Market Value in USD from 2009 to 2013

The pharmaceutical market was driven by a rise in healthcare spending and high growth in both emerging markets and the biologics segment. In 2013, cancer was the largest segment, accounting for 7% ($67 billion) of the global industry. This was closely followed by the pain and diabetes segments with shares of 6% and 5% respectively, according to IMS.

Key International Markets

  • North America was the largest market in 2013, with revenues exceeding $340 billion.
  • This was followed by Europe with revenues of $224 billion according to IMS.
  • Emerging countries in Asia and Latin America are forecast to grow rapidly. Increase in spending in these countries will be driven by rising incidence of disease, favorable government policies and improving healthcare infrastructure (and the multiplication of drug stores and pharmacies in large cities.

 Top Pharmaceutical Regional Markets' Growth in 2013

Pharmaceutical Key Players

Novartis was the pharmaceutical market leader in 2013 (thanks to a state-of-the-art drug discovery and development department) with revenues of $51 billion and a market share of 5%. Primary contributors to its sales were the drugs Gilenya and Affinitor. In 2014 Novartis is expected to file 10 new drugs with the U.S.’s Federal Drugs Administration (FDA). Pfizer was close behind Novartis with a 4% shareof the global market according to IMS. Pfizer too is expected to file six new drugs with the FDA in 2014.

The top ten players are forecast to collectively lose share from 35% in 2013 to 30% in 2017, according to IMS. Patent expiries over the next few years will eat into the revenues of most companies during this period.

Sanofi potential loss due to patent expiries is estimated to reach up to $8.1 billion. The company is then followed by Novartis, Roche, Astra-Zeneca and Eli Lilly with respectively potential losses of 7.7, 7.2, 6.7 and 6 billion dollars.  

Pharmaceutical Sales Forecast 

Pharmaceutical industry trends show that the global market is set to show steady growth in the next five years at a CAGR of 4-5%. Innovative on-prescritpion drugs and over-the-counter drugs entering the market and biologics such as targeted therapies for cancer will be key in driving growth.

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 37 000 reports

Global Pharmaceutical Markets

  • January 2015
    217 pages
  • Medical  

    Pharmaceutical  

    Cancer  

  • OECD  

    World  

    Europe  

View report >

Pharmaceutical Industry in the US Quarterly Update

  • December 2015
    7 pages
  • Pharmaceutical  

  • United States  

View report >

Pharmaceutical Market Analysis in Europe

  • October 2015
    51 pages
  • Healthcare Expe  

    Healthcare  

    Pharmaceutical  

  • Europe  

    World  

    OECD  

View report >

Pharmaceutical Industry in Japan

  • September 2015
    14 pages
  • Pharmaceutical  

  • Japan  

View report >

Pharmaceutical Industry in France

  • January 2013
    9 pages
  • Pharmaceutical  

  • France  

View report >

Pharmaceutical Markets in Germany

  • January 2015
    28 pages
  • Pharmaceutical  

  • Germany  

    Europe  

    World  

View report >

Pharmaceutical Industry in Italy

  • January 2015
    162 pages
  • Cancer  

    Infectious Dise  

    Influenza  

  • Italy  

    Europe  

View report >

Pharmaceutical Statistics in the UK and the US

  • February 2015
    186 pages
  • Pharmaceutical  

    Public Health  

  • United Kingdom  

    United States  

    North America  

View report >

Pharmaceutical Industry in Canada Forecast

  • January 2015
    32 pages
  • Pharmaceutical  

  • Canada  

View report >

Pharmaceutical Industry in Brazil Forecast

  • January 2014
    13 pages
  • Pharmaceutical  

  • Brazil  

View report >


About 22 000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 63 - $ 54 500)

A 33-Country Survey of the Infectious Disease Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers

A 33-Country Survey of the Infectious Disease Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers

  • $ 54 500
  • Industry report
  • February 2016
  • by Venture Planning Group

This report is delivered in 10-15 working days This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any othe ...

A 33-country Survey Of The Immunodiagnostics Market: Sa ...

February 2016 $ 47 500

A 33-country Survey Of The Automated Microbiology Marke ...

February 2016 $ 47 500

Cancer Bundle

January 2016 $ 24 225

Immunodiagnostics 2020: Clinical Chemistry, Drugs Of Ab ...

January 2016 $ 23 500

2016 Global Clinical Chemistry And Immunodiagnostic Mar ...

November 2015 $ 23 500

Infectious Diseases 2020: Supplier Shares, Competitive ...

January 2016 $ 21 100

2016 Global Infectious Disease Testing Market: Country ...

November 2015 $ 21 100

2016 Global Virology And Bacteriology Testing Market: C ...

November 2015 $ 21 100

2016 Future Horizons And Growth Strategies In The Globa ...

November 2015 $ 21 100

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.